Ericsson sues UK based mobile phone company Sendo for patent infringement
"Ericsson is the leading innovator in telecommunications and has made substantial investments in the development of various telecommunication standards," said Kasim Alfalahi, Vice President Patent Licensing. "As a result, we have built a strong portfolio of essential GSM and GPRS patents."
Ericsson is committed to make its technology available to all in the industry who desire to use it on fair and reasonable terms through licensing. Most of the world's manufacturers of GSM/GPRS mobile phones have already joined the Ericsson patent licensing program.
"Basically, all we ask is that companies who use technology invented by Ericsson compensate us for this, the same way we are prepared to compensate others for our use of their technology," Kasim Alfalahi said. "We believe that Sendo is using Ericsson patented technology, but they have so far not signed a license agreement with Ericsson. Under these circumstances we have no choice but to take Sendo to court."
Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world.
|
||||||
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
|
|
E-mail This Article |
|
Printer-Friendly Page |









